Alpha-1 Foundation, AARC Cooperate On Study To Test 5,000 COPD Patients For Alpha-1

Some 5,000 COPD patients will be tested to determine the prevalence of Alpha-1 Antitrypsin Deficiency (Alpha-1) in a study marking a major cooperative effort between the Alpha-1 Foundation and the American Association for Respiratory Care (AARC). The principal investigator is Robert A. Sandhaus, MD, PhD, of the Division of Pulmonary Medicine, National Jewish Medical and Research Center in Denver. Sandhaus is also the Clinical Director of the Alpha-1 Foundation. [click link for full article]

More: continued here

Filed under: Genetics on December 9th, 2007